Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Genetic Liver Disease
What kind of follow up or monitoring do you recommend for patients with at risk alpha-1-anti-trypsin phenotypes?
Related Questions
What would you your approach to evaluation and monitoring of a patient with elevated AMA and increased immunoglobulins with a low alkaline phosphatase?
How would you approach a referral for concern for hemochromatosis with ferritin elevation but otherwise normal iron studies?
How do you diagnose cystic fibrosis related liver disease?
What is your preferred approach to a patient with incidentally found low ceruloplasmin?
How would you differentiate neurologic manifestations of a patient with Wilson's disease versus manifestations of hepatic encephalopathy due to end-stage liver disease?
In what clinical scenario would you consider liver transplant evaluation for a patient with sickle cell hepatopathy?
How do you differentiate primary from secondary iron overload?
In Fontan-associated liver disease (FALD), what clinical scenario would lead you to pursue an evaluation for simultaneous liver-heart transplant as opposed to heart alone if there is evidence of fibrosis on a liver biopsy?
What is your approach to the management of extra-hepatic manifestations/complications of PBC?
What management considerations should we be aware of in the care of aging patients with biliary atresia?
